Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21+
SponsorNorthwell Health

About this trial

This is a qualitative and quantitative study that seeks to obtain information from patients with degenerative mitral valve prolapse and providers regarding factors important in deciding between surgical mitral valve repair (MVR) and transcatheter edge-to-edge repair (TEER). Findings from this study will provide data that can be used to develop decision aids that can assist patients in decision making between these two therapies and assist providers in integrating shared decision making the within the multidisciplinary heart valve team.

Eligibility criteria

Qualifiers

Age 21 years and older

Diagnosis of degenerative mitral valve regurgitation

Disqualifiers

Non-English speaking

Unable to consent on own behalf

Previous mitral surgery

Trial design

Treatments tested in this trial

  • Focus Groups/Quantitative Survey for Patients
  • Focus Group/Quantitative Survey for HCPs
  • Qualitative Focus Group

Treatment groups

150 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Northwell Health

Lead sponsor

West Virginia University

Collaborator

Cedars-Sinai Medical Center

Collaborator

The Cleveland Clinic

Collaborator

University of Kansas Medical Center

Collaborator

Saint Luke's Mid America Heart Institute

Collaborator